Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "ASH"

1984 News Found

Ashland Rad-Sure indicators approved by AABB Standards-Compliant product program
News | August 21, 2024

Ashland Rad-Sure indicators approved by AABB Standards-Compliant product program

Rad-Sure blood irradiation indicators are FDA 510 (k) cleared medical devices that offer positive visual verification of irradiation at the minimum specified dose


Wanbury appoints Prakash Venkatraman as President of API Business
People | August 14, 2024

Wanbury appoints Prakash Venkatraman as President of API Business

He recently served as Senior Vice President of the API business at Shilpa Pharma Life Sciences for over 3 years


Ashland completes second expansion of Viatel bioresorbable polymers manufacturing and R&D lab in Ireland
News | August 13, 2024

Ashland completes second expansion of Viatel bioresorbable polymers manufacturing and R&D lab in Ireland

This project is supported by the Irish Government through IDA Ireland


Health Ministry issues advisory to states in view of zika virus cases from Maharashtra
Policy | July 04, 2024

Health Ministry issues advisory to states in view of zika virus cases from Maharashtra

States urged to maintain a state of constant vigil through screening of pregnant women for Zika virus infection and monitoring the growth of foetus of expecting mothers who tested positive for Zika


Lilly's tirzepatide was superior to placebo for MASH resolution
Diagnostic Center | June 13, 2024

Lilly's tirzepatide was superior to placebo for MASH resolution

SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine


Lilly CFO Anat Ashkenazi resigns
People | June 09, 2024

Lilly CFO Anat Ashkenazi resigns

Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024


Elinzanetant significantly reduces frequency and severity of hot flashes associated with menopause
Diagnostic Center | May 17, 2024

Elinzanetant significantly reduces frequency and severity of hot flashes associated with menopause

Pivotal OASIS 1 and 2 Phase III studies of investigational compound elinzanetant achieved a statistically significant reduction in frequency and severity of vasomotor symptoms


Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
News | May 09, 2024

Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners

Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies


Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH
Diagnostic Center | February 28, 2024

Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows achieved groundbreaking results in liver disease due to MASH

Survodutide has potential to become best-in-class treatment for metabolic dysfunction-associated steatohepatitis


Ashland launches iSolve information on demand for F&B customers
News | February 15, 2024

Ashland launches iSolve information on demand for F&B customers

iSolveSM information on demand is the result of our focus on customer relationship